ADAR1 Capital Management, LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1940272 AUSTIN, TX

Position in CRNX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$45,730,233

+$4,349,732 QoQ

Shares Held

1,222,080

+7.3% QoQ

Ownership

1.15%

of shares outstanding

% of Portfolio

2.21%

of 13F equity value

Holder Rank

#27

of 266 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. CRNX ranks #7 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,804,703	$240,494,721
2	PTGX	Protagonist Therapeutics, Inc	960,863	$117,782,586
3	ROIV	Roivant Sciences Ltd.	3,157,008	$111,726,513
4	IMVT	Immunovant, Inc.	2,330,716	$89,802,487
5	ZLAB	Zai Lab Ltd	3,369,034	$64,011,646
6	AGIO	Agios Pharmaceuticals, Inc.	1,288,053	$47,799,646
7	CRNX	Crinetics Pharmaceuticals, Inc. This page	1,222,080	$45,730,233
8	CYTK	Cytokinetics Inc	457,907	$39,009,097

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,730,233	1,222,080	+7.3%	Shares	Sole	2026-08-14
2026-03-31	$41,380,501	1,139,331	+268.3%	Shares	Sole	2026-05-18
2025-12-31	$14,401,080	309,368	+24.6%	Shares	Sole	2026-02-18
2025-09-30	$10,344,527	248,368	+367.5%	Shares	Sole	2025-11-14
2025-06-30	$1,527,875	53,125	0.0%	Shares	Sole	2025-08-14
2025-03-31	$1,781,812	53,125	0.0%	Shares	Sole	2025-05-15
2024-12-31	$2,716,281	53,125	-39.9%	Shares	Sole	2025-02-13
2024-09-30	$4,518,517	88,425	+18.1%	Shares	Sole	2024-11-14
2024-06-30	$3,352,531	74,850	—	Shares	Sole	2024-08-13
No filing history on record for this holder in this stock.